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A prevalence survey in Kabul City showed that 2.7%
and 21.9% of persons have active leishmaniasis lesions or
scars, respectively. Incidence of disease was estimated to
be 2.9% (29 cases/1,000 persons per year; 95% confi-
dence interval 0.018 to 0.031). Disease was associated
with age and gender; logistic regression analyses showed
significant clustering of cases.
In Afghanistan, the majority of leishmaniasis cases arecaused by Leishmania tropica (1), which is transmitted
anthroponotically (i.e., humans are the reservoir) by the
sandfly (Phlebotomus sergenti) (2). Anthroponotic cuta-
neous leishmaniasis (ACL) is generally characterized by
large and/or multiple cutaneous lesions with a variable ten-
dency to self-cure (3). Because of sandfly exposure, most
lesions occur on the face, often leading to severe stigmati-
zation in affected persons (e.g., women with lesions are
often deemed unsuitable for marriage or raising children).
Anecdotal reports suggest that because of the political
instability and destruction of the housing and health infra-
structure during the Mojahedin and Taliban regimes, L.
tropica cases have increased during the past decade, with
current World Health Organization (WHO) estimates of
200,000 ACL cases in Kabul alone (4). Also, because of
several factors (the mass migration of L. tropica–infected
[and infectious] Afghan refugees; the sporadic treatment of
ACL cases by WHO and nongovernmental organizations;
and the virtual absence of vector-control strategies), L.
tropica has spread to areas where ACL was previously
nonendemic (e.g., northwestern Pakistan) (5).
The Study
Before developing an ACL-control strategy, we con-
ducted a cluster-based, house-to-house survey in Kabul
City between July and September 2001 to collect data on
the extent of ACL. The leishmaniasis transmission season
is between April and October. Each of the city’s 14 dis-
tricts was divided into random clusters according to the
district’s population size, for a total of 90 sample clusters;
30 neighboring households were surveyed in each cluster,
with the first household selected at random. A team of
medical staff diagnosed disease in household members on
the basis of presence or absence of ACL lesions or scars,
number of lesions, and date of lesion onset; members were
interviewed to collect demographic data such as gender
and age. Because of logistic constraints, parasitologic
diagnosis of ACL lesions (e.g., microscopic examination
or parasite culture) was not carried out. However, in
Afghanistan, ACL-like skin lesions from other causes are
rare, and our experience suggests that clinical diagnosis
has a sensitivity and specificity of >80% and >90%,
respectively (Reithinger et al., unpub. data). Written
approval to conduct the study was obtained from the
Afghan Ministry of Public Health. Informed consent was
obtained from study participants; all persons with active
cases surveyed were offered free antileishmanial treatment
at the HealthNet International clinic.
Of 26,892 persons surveyed, 726 (2.7%) and 5,900
(21.9%) had active leishmaniasis lesions or scars, respec-
tively. Of those persons with ACL lesions, the mean lesion
number was 2.4 (range 1–50) and the mean lesion duration
(to survey date) was 9.1 months (range 0.1–96). A total of
26,887 observations, with full disease and demographic
records, from 2,683 households from the 90 sample clus-
ters, were used in logistic regression analyses with a bina-
ry outcome variable (ACL lesion or scar). 
Four variables were created to assess the distribution of
leishmaniasis cases: the prevalence of active lesions in
other members of the same household, the prevalence of
scars in other members of the same household, the preva-
lence of active lesions in the nearest neighbor households,
and the prevalence of scars in the nearest neighbor house-
holds. The nearest neighbor households were defined in
terms of the survey protocol. In a given sample cluster, the
nearest neighbor to household 1 was household 2; the near-
est neighbors to household 2 were households 1 and 3; and
so forth. The logistic regressions with robust standard
errors (i.e., clustering of households to control for within-
household correlations) were also adjusted for age (contin-
uous to year of age at last birthday), gender, and sample
cluster (categorical 90 levels). All analyses were conduct-
ed in STATA 7 (Stata Corporation, College Station, TX).
The regression analyses show that female patients are at
significantly higher odds of having leishmaniasis lesions
or scars (Table). Odds of disease were associated with age:
elderly people are at slightly greater risk of having active
lesions; and elderly persons are less likely to have leishma-
niasis scars (the drop in scar prevalence in persons >12
years was significant, odds ratio: 0.994 (95% confidence
interval [CI] 0.991 to 0.997), p<0.001). The analyses
showed significant clustering of ACL within and between
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households (Table). A person’s probability of having an
active lesion was increased greatly if other lesions
appeared on persons in the same household (Figure, A) and
also (but less so) if other scars occurred on persons in the
same household. A person’s probability of having a scar
was greatly increased if persons with active lesions or
scars were present in the same household (Figure, B).
Finally, a person’s probability of having a scar was greatly
increased with the presence of persons with active lesions
or scars in neighboring households (Figure, C). No signif-
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Table. Within- and between-household clustering of anthroponotic cutaneous leishmaniasis lesions and scars, Kabul City, 
Afghanistana 
Outcome variableb 
 Explanatory variables Lesion Scar 
Within-household prevalence OR (CI) OR (CI) 
Prevalence of lesions in other household members 132.3 (67.3 to 259.8) p<0.001 3.728 (2.799 to 4.964) p<0.001 
Prevalence of scars in other household members 1.988 (1.500 to 2.635) p<0.001 48.24 (41.79 to 55.68) p<0.001 
Between-household prevalence   
Prevalence of lesions in nearest neighbor households 2.323 (0.984 to 5.486) NS 1.585 (1.036 to 1.353) p<0.05 
Prevalence of scars in nearest neighbor households 1.376 (0.957 to 1.980) NS 1.184 (1.036 to 1.353) p<0.05 
Other   
Age 1.005 (1.000 to 1.009) p<0.05 1.013 (1.011 to 1.015) p<0.001 
Sex (female relative to male) 1.383 (1.177 to 1.626) p<0.001 1.186 (1.108  to 1.270) p<0.001 
Sampling areac Chi square=213.6, d.f.=89 p<0.001 Chi square=330.8, d.f.=89 p<0.001 
Overall model fit Pseudo R2 = 11.89% p<0.0001 Pseudo R2=22.72 p<0.0001 
aAbbreviations used: OR, odds ratio; CI, 95% confidence intervals; d.f., degrees of freedom; NS, not significant. 
bThe statistical model controlled for age (in years), sex, and sampling area (a total of 90 areas), while the standard errors were adjusted for sampling of persons at the 
household level. 
cThe overall significance of the variable is shown rather than the ORs for the 90 different sampling areas. 
 
Figure. A, the average probability of having a lesion at different levels of lesion prevalence recorded among other members of the same
household (open circles) and the unadjusted fit (solid line) from the logistic regression. B, the average probability of having a scar at dif-
ferent levels of scar prevalence recorded in other members of the same household (open circles) and the unadjusted fit (solid line) from
the logistic regression. C, average probability of having a scar at different levels of scar prevalence in nearest neighbor households (open
circles) and the unadjusted fit (solid line) from the logistic regression. D, force of infection, λ, can be estimated from the age-prevalence
data, where the proportion, P, of persons with ACL at age a (where a is age at last birthday plus 0.5 years) is given by P(a) = 1-exp(-λa)
(6). If one assumes that age-independent transmission started 12 years earlier (1), λ was estimated by maximum likelihood by using the
observed age-prevalence data for children <12 y of age.
icant clustering of ACL lesions occurred between house-
holds; however, the sample size was small for analyses.
Overall, these findings are consistent with clustering of
ACL transmission, including transmission in areas where
previous transmission has occurred (because of association
with scar prevalence). When maximum likelihood meth-
ods (6) are used, the average annual force of ACL infection
(λ) was estimated to be 0.029 per year (29 cases/1,000 per-
sons per year; 95% CI 0.028 to 0.031) over the past 12
years (Figure, D).
Conclusions
Currently six clinics provide leishmaniasis diagnostic
and treatment services in Kabul; an estimated 20% of the
total 67,500 patients (based on the observed prevalence of
2.7% and a total 2.5 million population for Kabul) are
diagnosed and treated. Whether this fact alone could
explain the extent and duration of the leishmaniasis epi-
demic in Kabul is uncertain. Our analyses show that per-
sons are at high risk for active ACL when a high propor-
tion of persons with ACL scars are in the same or neigh-
boring households. The likely explanation for this finding
is that sandfly distribution and abundance are patchy but
stable over time. The high prevalence of persons with
active ACL in Kabul and the comparatively high ACL inci-
dence show that ACL-control strategies (e.g., increasing
the number of clinics providing treatment facilities or pro-
viding personal protection methods against sandflies)
should be conducted soon. We demonstrate that a blanket-
coverage ACL-control strategy is not necessary: transmis-
sion of this disease is focalized, and interventions (e.g.,
household insecticide spraying, insecticide-impregnated
bednets or chaddars) (5) targeting households with a high
proportion of persons with leishmaniasis lesions or scars or
city districts containing a high number of high transmis-
sion clusters should have a major impact on transmission
in Kabul. 
The international donor community often considers
ACL to be of peripheral importance (e.g., the disease was
not included in the basic package of health services for
Afghanistan) (7) because this disease has no impact on
death rates and patient treatment costs (usually
U.S.$15–200 [8]) are not recovered. Failure to implement
a control strategy for this disease will likely lead to an
increase in its impact and social stigmatization and repre-
sent further problems for a health infrastructure already
crippled by 20 years of war.
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